Phenyloxazolidinones having a C--C bond to 4-8 membered heterocy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548231, A61K 3142, C07D41310

Patent

active

060432667

ABSTRACT:
A compound of Formula (I): ##STR1## or pharmaceutical acceptable salts thereof wherein X is S(O).sub.g or O; R.sub.2 is H, methyl, or OH; R.sub.3 and R.sub.4 are independently H or halo; R.sub.5 is H, C.sub.1-12 alkyl, optionally substituted with one or more halo, C.sub.3-12 cycloalkyl, C.sub.1-6 alkoxy; and g is 0, 1, or 2. The compounds are useful antimicrobial agents.

REFERENCES:
patent: 4476136 (1984-10-01), Dostert et al.
patent: 4705799 (1987-11-01), Gregory
patent: 4948801 (1990-08-01), Carlson et al.
patent: 5130316 (1992-07-01), Carson et al.
patent: 5254577 (1993-10-01), Carlson et al.
patent: 5547950 (1996-08-01), Hutchinson et al.
patent: 5565571 (1996-10-01), Barbachyn et al.
patent: 5668286 (1997-09-01), Yamada et al.
patent: 5684023 (1997-11-01), Reidl et al.
patent: 5698574 (1997-12-01), Reidl et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phenyloxazolidinones having a C--C bond to 4-8 membered heterocy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenyloxazolidinones having a C--C bond to 4-8 membered heterocy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyloxazolidinones having a C--C bond to 4-8 membered heterocy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1326385

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.